Ignite Creation Date:
2025-12-24 @ 6:52 PM
Ignite Modification Date:
2026-01-24 @ 2:26 AM
Study NCT ID:
NCT06575257
Status:
RECRUITING
Last Update Posted:
2024-08-28
First Post:
2024-08-26
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Neoadjuvant Therapy of Darolutamide Plus ADT for High Risk Prostate Cancer
Sponsor:
Xijing Hospital
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-05-01
Start Date Type:
ACTUAL
Primary Completion Date:
2026-05
Primary Completion Date Type:
ESTIMATED
Completion Date:
2029-05
Completion Date Type:
ESTIMATED
First Submit Date:
2024-08-26
First Submit QC Date:
None
Study First Post Date:
2024-08-28
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-08-26
Last Update Post Date:
2024-08-28
Last Update Post Date Type:
ACTUAL